Paloma Partners Management CO Seagen Inc. Transaction History

Paloma Partners Management CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$108.81 - $179.33 $354,394 - $584,077	-3,257 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$119.61 - $157.85 $4.29 Million - $5.66 Million	-35,867 Reduced 91.68%	3,257 $469,000
Q4 2021 Feb 14, 2022	BUY	$142.57 - $190.86 $4.54 Million - $6.07 Million	31,817 Added 435.43%	39,124 $6.05 Million
Q2 2021 Aug 16, 2021	SELL	$135.08 - $161.1 $4.01 Million - $4.79 Million	-29,704 Reduced 80.26%	7,307 $1.15 Million
Q1 2021 May 17, 2021	BUY	$137.51 - $190.8 $5.09 Million - $7.06 Million	37,011 New	37,011 $5.14 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.